Vinbarbital

Vinbarbital is a barbiturate that was first synthesized in 1927. It is an alkyl derivative of barbituric acid and is classified as a sedative and hypnotic. Vinbarbital is not commonly used in modern medicine due to the risk of dependence and the availability of safer alternatives.

History

Vinbarbital was first synthesized in 1927 by the German pharmaceutical company Bayer. It was marketed under the brand name Vinoton and was used as a sedative and hypnotic. However, due to the risk of dependence and the development of safer alternatives, it is no longer commonly used in modern medicine.

Pharmacology

As a barbiturate, vinbarbital works by increasing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter in the brain. GABA is an inhibitory neurotransmitter, meaning it reduces the activity of the neurons it binds to. By increasing the activity of GABA, vinbarbital helps to calm the brain and induce sleep.

Side Effects

The side effects of vinbarbital can include drowsiness, dizziness, nausea, and vomiting. In severe cases, it can cause respiratory depression, coma, and even death. Long-term use of vinbarbital can lead to physical and psychological dependence.

See Also

• Barbiturate
• Barbituric acid
• Sedative
• Hypnotic
• Dependence

Vinbarbital Resources
Latest articles Most recent articles Ongoing trials	Wikipedia